Pharmahungary Group as a Hungarian SME is ready for Horizon 2020 applications and are offering innovative preclinical and clinical R&D services.
Clinical Director and Founder & CEO attended Bioequivalence Symposium, Biological and Non-Biological Complex Drugs
3rd International Symposium on Scientific and Regulatory Advances in Biological and Non – Biological Complex Drugs: A to Z in Bioequivalence
Development and clinical trials with Medical Devices, GCP lecture by Clinical Director
Lecture of Clinical Director for board certified clinical pharmacologists.
Presentation of Founder & CEO at ICI Meeting 2018, Tel Aviv, Israel
Development of post-myocardial infarction-induced heart failure in closed-chest coronary occlusion/reperfusion models in landrace pigs and Göttingen minipigs: feasibility and translational values, presentation by Founder & CEO
35th Annual Meeting of the European Section of the ISHR
35th Annual Meeting of the European Section of the ISHR, Amsterdam, The Netherlands